Ad
Tuesday, 28 February 2017
Roche to start new trial of AC Immune drug against Alzheimer's
ZURICH (Reuters) - Roche is starting a second late-stage trial of investigational Alzheimer's drug crenezumab that it is developing with Swiss biotech AC Immune, shrugging off failures of similar drugs against the memory-robbing disease.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment